Halozyme Therapeutics Inc., of San Diego, named Robert Engler to its board. Jonathan Lim will become chairman. Also, David Ramsay was appointed vice president and chief financial officer, Don Kennard vice president of regulatory affairs and quality assurance, and Carolyn Rynard vice president of product development and manufacturing.

Harvard Bioscience Inc., of Holliston, Mass., promoted David Strack to president of Genomic Solutions.

ICOS Corp., of Bothell, Wash., appointed Teresa Beck and Vaughn Bryson to the board.

InKine Pharmaceutical Co. Inc., of Blue Bell, Pa., appointed Del Humphreys senior vice president of sales.

Leerink Swann & Co., of Boston, appointed Andrew Oh director and analyst of equity research.

MetaWorks Inc., of Medford, Mass., appointed Robert Makuch chief scientific adviser.

MichBio, of Ann Arbor, Mich., appointed Randal Charlton to its board, and Edward Pagani president of the association.

NeoGenomics Inc., of Fort Myers, Fla., appointed Gary LaBarge area sales manager for Southeast Florida.

NeoStem, of Agoura Hills, Calif., named Edward Garnett vice president of sales and marketing.

NeurogesX Inc., of San Carlos, Calif., added Jean-Jacques Bienaime to its board.

Novavax Inc., of Columbia, Md., appointed Rahul Singhvi vice president of pharmaceutical development and manufacturing operations.

Oncolytics Biotech Inc., of Calgary, Alberta, appoin-ted Mark Lievonen to its board.

Orion Genomics LLC, of St. Louis, promoted Jeffrey Jeddeloh to director of biomarker discovery and detection.

Oxigene Inc., of Waltham, Mass., appointed James Murphy chief financial officer and Scott Young chief operating officer. It also appointed Eugene de Juan to the clinical trial advisory board.

Paradigm Genetics Inc., of Research Triangle Park, N.C., appointed Douglas Morton to its board.

Pharmos Corp., of Iselin, N.J., appointed Ray McKee vice president of investor relations and corporate development, and Harry Atkins senior director of marketing and business development.

Prana Biotechnology Ltd., of Melbourne, Australia, appointed Jonas Alsenas to its board.

Prestwick Pharmaceuticals Inc., of Washington, D.C., appointed Melvin Booth to its board.

Pro-Pharmaceuticals Inc., of Newton, Mass., appointed Jerald Rome to its board.